HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy of propafenone in paramyotonia congenita.

AuthorsE Alfonsi, I M Merlo, M Tonini, S Ravaglia, R Brugnoni, A Gozzini, A Moglia
JournalNeurology (Neurology) Vol. 68 Issue 13 Pg. 1080-1 (Mar 27 2007) ISSN: 1526-632X [Electronic] United States
PMID17389319 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Anti-Arrhythmia Agents
  • Genetic Markers
  • NAV1.4 Voltage-Gated Sodium Channel
  • SCN4A protein, human
  • Sodium Channel Blockers
  • Sodium Channels
  • Propafenone
Topics
  • Action Potentials (drug effects, genetics)
  • Adult
  • Anti-Arrhythmia Agents (administration & dosage)
  • DNA Mutational Analysis
  • Drug Administration Schedule
  • Genetic Markers (genetics)
  • Genetic Testing
  • Humans
  • Male
  • Muscle Hypertonia (drug therapy, genetics, physiopathology)
  • Muscle, Skeletal (drug effects, metabolism, physiopathology)
  • Mutation (genetics)
  • Myotonic Disorders (drug therapy, genetics, physiopathology)
  • NAV1.4 Voltage-Gated Sodium Channel
  • Paralysis (drug therapy, genetics, physiopathology)
  • Propafenone (administration & dosage)
  • Sodium Channel Blockers (administration & dosage)
  • Sodium Channels (drug effects, genetics, metabolism)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: